Bond Amgen 2.6% ( US031162CJ71 ) in USD
| Issuer | Amgen | ||||||||||||||||||||||||||||||||
| Market price | 92.91 % ▼ | ||||||||||||||||||||||||||||||||
| Country | United States
|
||||||||||||||||||||||||||||||||
| ISIN code |
US031162CJ71 ( in USD )
|
||||||||||||||||||||||||||||||||
| Interest rate | 2.6% per year ( payment 2 times a year) | ||||||||||||||||||||||||||||||||
| Maturity | 19/08/2026 - Bond has expired | ||||||||||||||||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||||||||||||||
| Total amount | 1 250 000 000 USD | ||||||||||||||||||||||||||||||||
| Cusip | 031162CJ7 | ||||||||||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||
| Moody's rating | Baa1 ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||
| Detailed description |
Amgen is a leading biotechnology company focused on developing and delivering innovative therapies for serious illnesses in areas such as oncology, cardiovascular disease, and inflammation. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162CJ71, pays a coupon of 2.6% per year. The coupons are paid 2 times per year and the Bond maturity is 19/08/2026 The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162CJ71, was rated Baa1 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162CJ71, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
Français
Italiano
United States